Victory Capital Management Inc. cut its position in Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) by 20.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,386 shares of the company’s stock after selling 1,640 shares during the quarter. Victory Capital Management Inc. owned 0.09% of Semler Scientific worth $220,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in SMLR. CWM LLC raised its position in Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after purchasing an additional 744 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Semler Scientific by 27.1% during the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after buying an additional 1,320 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Semler Scientific in the fourth quarter valued at about $301,000. BOKF NA bought a new position in Semler Scientific in the first quarter valued at about $227,000. Finally, Financial Strategies Group Inc. acquired a new position in Semler Scientific during the second quarter worth about $263,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Semler Scientific
In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the transaction, the chief executive officer now owns 60,220 shares of the company’s stock, valued at $1,707,237. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 13.00% of the stock is currently owned by company insiders.
Semler Scientific Trading Down 4.4 %
Semler Scientific (NASDAQ:SMLR – Get Free Report) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.56 by $0.08. The business had revenue of $14.47 million during the quarter. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Stories
- Five stocks we like better than Semler Scientific
- How to Choose Top Rated Stocks
- The Average 401k Balance by Age Explained
- How to Invest in Blue Chip Stocks
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is a Dividend King?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR – Free Report).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.